79 related articles for article (PubMed ID: 22260960)
1. Targeting Stat3 suppresses growth of U251 cell-derived tumours in nude mice.
Xu Y; Li X; Zhang S; Shen D; Li H; Wu Y; Qiu Y; Ji Y; Chen F
J Clin Neurosci; 2012 Mar; 19(3):443-6. PubMed ID: 22260960
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of STAT3 and ErbB2 suppresses tumor growth, enhances radiosensitivity, and induces mitochondria-dependent apoptosis in glioma cells.
Gao L; Li F; Dong B; Zhang J; Rao Y; Cong Y; Mao B; Chen X
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1223-31. PubMed ID: 20610043
[TBL] [Abstract][Full Text] [Related]
3. STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo.
Huang C; Jiang T; Zhu L; Liu J; Cao J; Huang KJ; Qiu ZJ
Int J Oncol; 2011 Jun; 38(6):1637-44. PubMed ID: 21479358
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice.
Zhang X; Zhang J; Wang L; Wei H; Tian Z
BMC Cancer; 2007 Aug; 7():149. PubMed ID: 17683579
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of signal transducer and activator of transcription 3 siRNA on human breast cancer in xenograft mice.
Yang Z; Cai JH; Xie SJ; Li GX; Song WQ; Yan QH; Yan L; Zhang F
Chin Med J (Engl); 2011 Jun; 124(12):1854-61. PubMed ID: 21740845
[TBL] [Abstract][Full Text] [Related]
6. RNA interference-mediated silencing of focal adhesion kinase inhibits growth of human malignant glioma xenograft in nude mice.
Wang GJ; Ma YP; Yang Y; Zhang N; Wang W; Liu SY; Chen LJ; Jiang Y; Zhao X; Wei YQ; Deng HX
Cell Biol Int; 2011 Aug; 35(8):841-8. PubMed ID: 21247411
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of STAT3 expression by RNAi suppresses growth and induces apoptosis and differentiation in glioblastoma stem cells.
Li GH; Wei H; Lv SQ; Ji H; Wang DL
Int J Oncol; 2010 Jul; 37(1):103-10. PubMed ID: 20514402
[TBL] [Abstract][Full Text] [Related]
8. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of STAT3 potentiates growth, survival, and radioresistance of non-small-cell lung cancer (NSCLC) cells.
Yin ZJ; Jin FG; Liu TG; Fu EQ; Xie YH; Sun RL
J Surg Res; 2011 Dec; 171(2):675-83. PubMed ID: 20605584
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H
Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of decoy-ODN targeting activated STAT3 on human glioma growth in vivo.
Shen J; Li R; Li G
In Vivo; 2009; 23(2):237-43. PubMed ID: 19414409
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of Stat3 expression using RNAi inhibits growth of laryngeal tumors in vivo.
Gao LF; Wen LJ; Yu H; Zhang L; Meng Y; Shao YT; Xu DQ; Zhao XJ
Acta Pharmacol Sin; 2006 Mar; 27(3):347-52. PubMed ID: 16490172
[TBL] [Abstract][Full Text] [Related]
13. Targeting YB-1 in HER-2 overexpressing breast cancer cells induces apoptosis via the mTOR/STAT3 pathway and suppresses tumor growth in mice.
Lee C; Dhillon J; Wang MY; Gao Y; Hu K; Park E; Astanehe A; Hung MC; Eirew P; Eaves CJ; Dunn SE
Cancer Res; 2008 Nov; 68(21):8661-6. PubMed ID: 18974106
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo.
Gao L; Zhang L; Hu J; Li F; Shao Y; Zhao D; Kalvakolanu DV; Kopecko DJ; Zhao X; Xu DQ
Clin Cancer Res; 2005 Sep; 11(17):6333-41. PubMed ID: 16144938
[TBL] [Abstract][Full Text] [Related]
15. Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor.
Mishima K; Johns TG; Luwor RB; Scott AM; Stockert E; Jungbluth AA; Ji XD; Suvarna P; Voland JR; Old LJ; Huang HJ; Cavenee WK
Cancer Res; 2001 Jul; 61(14):5349-54. PubMed ID: 11454673
[TBL] [Abstract][Full Text] [Related]
16. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.
Hellsten R; Johansson M; Dahlman A; Dizeyi N; Sterner O; Bjartell A
Prostate; 2008 Feb; 68(3):269-80. PubMed ID: 18163422
[TBL] [Abstract][Full Text] [Related]
17. [Growth inhibition of breast cancer cells in vitro and in vivo by siRNA targeting signal transducers and activators of transcription 3].
Yang Z; Yan L; Zhang F; Yan QH; Song WQ; Wang FA; Cai JH
Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):819-24. PubMed ID: 21223686
[TBL] [Abstract][Full Text] [Related]
18. Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: an implication for the antitumor potential of flavonoids.
Selvendiran K; Koga H; Ueno T; Yoshida T; Maeyama M; Torimura T; Yano H; Kojiro M; Sata M
Cancer Res; 2006 May; 66(9):4826-34. PubMed ID: 16651438
[TBL] [Abstract][Full Text] [Related]
19. Abrogation of constitutive STAT3 activity sensitizes human hepatoma cells to TRAIL-mediated apoptosis.
Kusaba M; Nakao K; Goto T; Nishimura D; Kawashimo H; Shibata H; Motoyoshi Y; Taura N; Ichikawa T; Hamasaki K; Eguchi K
J Hepatol; 2007 Oct; 47(4):546-55. PubMed ID: 17602782
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 overexpression and response to bortezomib treatment in a breast cancer model.
Ishii Y; Pirkmaier A; Alvarez JV; Frank DA; Keselman I; Logothetis D; Mandeli J; O'Connell MJ; Waxman S; Germain D
J Natl Cancer Inst; 2006 Sep; 98(17):1238-47. PubMed ID: 16954476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
